Logo image of RKLB

ROCKET LAB CORP (RKLB) Stock Fundamental Analysis

USA - NASDAQ:RKLB - US7731211089 - Common Stock

47.79 USD
+0.61 (+1.29%)
Last: 9/19/2025, 8:00:01 PM
47.21 USD
-0.58 (-1.21%)
Pre-Market: 9/22/2025, 4:51:36 AM
Fundamental Rating

3

Taking everything into account, RKLB scores 3 out of 10 in our fundamental rating. RKLB was compared to 69 industry peers in the Aerospace & Defense industry. RKLB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RKLB is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RKLB has reported negative net income.
RKLB had a negative operating cash flow in the past year.
RKLB had negative earnings in each of the past 5 years.
In the past 5 years RKLB always reported negative operating cash flow.
RKLB Yearly Net Income VS EBIT VS OCF VS FCFRKLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

RKLB has a Return On Assets of -14.89%. This is in the lower half of the industry: RKLB underperforms 72.46% of its industry peers.
RKLB has a Return On Equity of -33.60%. This is in the lower half of the industry: RKLB underperforms 72.46% of its industry peers.
Industry RankSector Rank
ROA -14.89%
ROE -33.6%
ROIC N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
RKLB Yearly ROA, ROE, ROICRKLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

With a decent Gross Margin value of 29.04%, RKLB is doing good in the industry, outperforming 66.67% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for RKLB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RKLB Yearly Profit, Operating, Gross MarginsRKLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

RKLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RKLB has been increased compared to 1 year ago.
RKLB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RKLB is higher compared to a year ago.
RKLB Yearly Shares OutstandingRKLB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
RKLB Yearly Total Debt VS Total AssetsRKLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

RKLB has an Altman-Z score of 15.49. This indicates that RKLB is financially healthy and has little risk of bankruptcy at the moment.
RKLB has a Altman-Z score of 15.49. This is amongst the best in the industry. RKLB outperforms 97.10% of its industry peers.
RKLB has a Debt/Equity ratio of 0.60. This is a neutral value indicating RKLB is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.60, RKLB perfoms like the industry average, outperforming 43.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z 15.49
ROIC/WACCN/A
WACC9.65%
RKLB Yearly LT Debt VS Equity VS FCFRKLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

RKLB has a Current Ratio of 2.67. This indicates that RKLB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.67, RKLB is in line with its industry, outperforming 55.07% of the companies in the same industry.
A Quick Ratio of 2.33 indicates that RKLB has no problem at all paying its short term obligations.
The Quick ratio of RKLB (2.33) is better than 72.46% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.33
RKLB Yearly Current Assets VS Current LiabilitesRKLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for RKLB have decreased strongly by -28.57% in the last year.
The Revenue has grown by 54.37% in the past year. This is a very strong growth!
RKLB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 55.23% yearly.
EPS 1Y (TTM)-28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.5%
Revenue 1Y (TTM)54.37%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%36%

3.2 Future

RKLB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.40% yearly.
The Revenue is expected to grow by 32.13% on average over the next years. This is a very strong growth
EPS Next Y-16.61%
EPS Next 2Y27.89%
EPS Next 3Y31.1%
EPS Next 5Y32.4%
Revenue Next Year35.12%
Revenue Next 2Y43.83%
Revenue Next 3Y39.59%
Revenue Next 5Y32.13%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RKLB Yearly Revenue VS EstimatesRKLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
RKLB Yearly EPS VS EstimatesRKLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RKLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RKLB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RKLB Price Earnings VS Forward Price EarningsRKLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RKLB Per share dataRKLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as RKLB's earnings are expected to grow with 31.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.89%
EPS Next 3Y31.1%

More info and screens

0

5. Dividend

5.1 Amount

RKLB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROCKET LAB CORP

NASDAQ:RKLB (9/19/2025, 8:00:01 PM)

Premarket: 47.21 -0.58 (-1.21%)

47.79

+0.61 (+1.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners61.47%
Inst Owner Change6.48%
Ins Owners0.68%
Ins Owner Change-5.07%
Market Cap23.05B
Analysts79.05
Price Target46.62 (-2.45%)
Short Float %12.57%
Short Ratio2.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.65%
Min EPS beat(2)-11.38%
Max EPS beat(2)8.09%
EPS beat(4)3
Avg EPS beat(4)3.2%
Min EPS beat(4)-11.38%
Max EPS beat(4)12.21%
EPS beat(8)7
Avg EPS beat(8)8.2%
EPS beat(12)8
Avg EPS beat(12)4.25%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.82%
Min Revenue beat(2)-0.99%
Max Revenue beat(2)4.63%
Revenue beat(4)2
Avg Revenue beat(4)0.87%
Min Revenue beat(4)-0.99%
Max Revenue beat(4)4.63%
Revenue beat(8)2
Avg Revenue beat(8)-1.29%
Revenue beat(12)5
Avg Revenue beat(12)-0.34%
Revenue beat(16)8
Avg Revenue beat(16)1.42%
PT rev (1m)23.4%
PT rev (3m)61.55%
EPS NQ rev (1m)-2.6%
EPS NQ rev (3m)-13.2%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.36%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)2.53%
Revenue NY rev (1m)0.62%
Revenue NY rev (3m)2.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 45.72
P/FCF N/A
P/OCF N/A
P/B 33.49
P/tB 40.91
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS1.05
BVpS1.43
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.89%
ROE -33.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.04%
FCFM N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 268.86%
Cap/Sales 18.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.33
Altman-Z 15.49
F-Score4
WACC9.65%
ROIC/WACCN/A
Cap/Depr(3y)174.96%
Cap/Depr(5y)206.2%
Cap/Sales(3y)19.28%
Cap/Sales(5y)34.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.5%
EPS Next Y-16.61%
EPS Next 2Y27.89%
EPS Next 3Y31.1%
EPS Next 5Y32.4%
Revenue 1Y (TTM)54.37%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%36%
Revenue Next Year35.12%
Revenue Next 2Y43.83%
Revenue Next 3Y39.59%
Revenue Next 5Y32.13%
EBIT growth 1Y-28.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.45%
EBIT Next 3Y44.65%
EBIT Next 5Y31.86%
FCF growth 1Y-70.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.93%
OCF growth 3YN/A
OCF growth 5YN/A